HCV Screening under Chiron showed effectiveness at testing when samples from North London Blood Transfusion Centre donations had tested positive when blind tested. Read more about HCV Screening under Chiron showed effectiveness at testing when samples from North London Blood Transfusion Centre donations had tested positive when blind tested.
3,282 samples screened for ALT and anti-HBc in the NBTS three-centre study had been tested using the first-generation Chiron/Ortho ELISA test and the test was considered to be reproducible, robust and meaningful, but further study was needed. Read more about 3,282 samples screened for ALT and anti-HBc in the NBTS three-centre study had been tested using the first-generation Chiron/Ortho ELISA test and the test was considered to be reproducible, robust and meaningful, but further study was needed.
A full report of the Ortho and Abbott trial was produced by Dr Edward Follett in Glasgow. Read more about A full report of the Ortho and Abbott trial was produced by Dr Edward Follett in Glasgow.
Dr Gunson did not believe any delay was caused by RIBA II not being available but it was due to the logistics of transferring samples from three RTCs to each of their confirmatory laboratories and the fact that 65 PCRs took a long time to complete. Read more about Dr Gunson did not believe any delay was caused by RIBA II not being available but it was due to the logistics of transferring samples from three RTCs to each of their confirmatory laboratories and the fact that 65 PCRs took a long time to complete.
Dr Rejman wrote to Dr Gunson requesting amendments to the article to mitigate criticism relating to the timeline for introducing screening, and specifically the delay due to lack of supplementary testing. Read more about Dr Rejman wrote to Dr Gunson requesting amendments to the article to mitigate criticism relating to the timeline for introducing screening, and specifically the delay due to lack of supplementary testing.
To accommodate the slippage of the unavailability of test kits, Mr Macleod and Dr Metters postponed the introduction of routine anti-HCV screening until 1 September 1991. Read more about To accommodate the slippage of the unavailability of test kits, Mr Macleod and Dr Metters postponed the introduction of routine anti-HCV screening until 1 September 1991.
Dr Gunson confirmed he approved the new generation Abbott Hepatitis C antibody test. Read more about Dr Gunson confirmed he approved the new generation Abbott Hepatitis C antibody test.
Dr Dow had used the new generation Abbott ELISA to retest the 69 reactive samples from the multi-centre study. Only 7 were repeatedly reactive, including the 6 which had previously tested positive under supplemental RIBA and PCR testing. The new generation test was likely to be more specific and cause fewer false positive results. Read more about Dr Dow had used the new generation Abbott ELISA to retest the 69 reactive samples from the multi-centre study. Only 7 were repeatedly reactive, including the 6 which had previously tested positive under supplemental RIBA and PCR testing. The new generation test was likely to be more specific and cause fewer false positive results.
"The Guardian" wrote that the most immediate concern facing the Department of Health was how to set up a mechanism and find the staff to tell donors the implications of carrying Hepatitis C antibodies. Read more about "The Guardian" wrote that the most immediate concern facing the Department of Health was how to set up a mechanism and find the staff to tell donors the implications of carrying Hepatitis C antibodies.
Professor Cash wrote to Dr Gunson to ask whether Dr Barbara might be persuaded to include SNBTS samples which had been tested for ALT in the North London Blood Transfusion Centre anti-HCV screening trial. Read more about Professor Cash wrote to Dr Gunson to ask whether Dr Barbara might be persuaded to include SNBTS samples which had been tested for ALT in the North London Blood Transfusion Centre anti-HCV screening trial.